C12N 9/1088
Glutathione transferase
Official title: {Glutathione transferase (2.5.1.18)}
C12N9/1088 (Glutathione transferase) appears on 126 US grants and 127 published applications in this corpus.
Search patents in C12N- Granted patents
- 126
- Published applications
- 127
- Assignees
- 122
- Inventors
- 364
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 10 | 0 |
| 2000 | 9 | 0 |
| 2001 | 8 | 0 |
| 2002 | 7 | 5 |
| 2003 | 3 | 6 |
| 2004 | 5 | 4 |
| 2005 | 1 | 4 |
| 2006 | 3 | 8 |
| 2007 | 1 | 3 |
| 2008 | 2 | 1 |
| 2009 | 1 | 8 |
| 2010 | 2 | 3 |
| 2011 | 3 | 2 |
| 2012 | 3 | 8 |
| 2013 | 5 | 7 |
| 2014 | 1 | 2 |
| 2015 | 1 | 6 |
| 2016 | 6 | 8 |
| 2017 | 6 | 4 |
| 2018 | 2 | 9 |
| 2019 | 9 | 6 |
| 2020 | 4 | 6 |
| 2021 | 5 | 7 |
| 2022 | 3 | 5 |
| 2023 | 2 | 3 |
| 2024 | 2 | 4 |
| 2025 | 0 | 3 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- Method for biotransformation of trichothecenes4 Aug 2026US 12,698,483 B2DSM Austria GmbH
- Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction20 Jan 2026US 12,527,822 B2City of Hope
- Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods16 Jul 2024US 12,037,611 B2R & D Systems, Inc.
- Metabolic enzyme-induced micro-nano plastic particle biodegradation method and product analysis method therefor9 Apr 2024US 11,952,468 B2Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
- New high expression and high activity n-glycosidases, methods of production and applications thereof8 Oct 2026US 2026/0308562 A1Centre National de la Recherche Scientifique (CNRS)
- Compositions and methods for enhancing drug resistance in cells10 Sep 2026US 2026/0265712 A1Medici Therapeutics, Inc.
- Recombinant host cells with improved production of tetraketide derivatives27 Aug 2026US 2026/0250728 A1Iptector Assets Aps
- Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction25 Jun 2026US 2026/0174803 A1City of Hope
- Inhibitors of nfat and nfkb signaling for improving immune cell function30 Apr 2026US 2026/0116933 A1Memorial Hospital for Cancer and Allied Diseases
Most cited
By later US patents
- Glutathione S-transferase sequence variants138US 7,390,894 B2Mayo Foundation for Medical Education and Research · 2008
- Isolation of enzymes104US 6,184,012 B2Medical Research Council · 2001
- Nucleic acids and proteins from streptococcus groups A and B59US 9,738,693 B2J. Craig Venter Institute, Inc. · 2017
- Nucleic acids and proteins from Streptococcus groups A and B59US 9,840,538 B2J. Craig Venter Institute, Inc. · 2017
- Sequence and method for genetic engineering of proteins with cell membrane translocating activity43US 6,432,680 B1Vanderbilt University · 2002